Biosort Secures More Than NOK 100 Million to Commercialize Individual-Based Lice Control

Biosort Secures More Than NOK 100 Million to Commercialize Individual-Based Lice Control

Biosort, best known for the development license project iFarm, has secured more than NOK 100 million from a strong group of aquaculture and technology investors to bring its individual-based lice control system to market.

Investors include Grieg Kapital, Hatch Blue, IVC, Farvatn, and Futurum Ventures, together with existing owners.

The capital will support final development and market introduction of Biosort’s next-generation, lice control technology.  The system is designed to efficiently remove lice at an early stage, preventing uncontrolled lice population growth and reducing the need for full-pen interventions.

“This funding takes us from development into commercial sales. Our focus is simple: continuous lice removal to suppress lice development and greatly reduce needs for well-boat treatments. The goal is improved welfare, lower mortality, better biological control, and ultimately making fish thrive.” said Geir Stang Hauge, CEO of Biosort.

Founded in 2010, Biosort has developed advanced machine vision, AI, and FishID technology capable of identifying and tracking individual salmon. The system now combines early lice removal with data on individual fish.

“We have followed Biosort for several years and are impressed by the team and their technology. Sea lice remain one of the greatest challenges in salmon farming, and Biosort’s approach has the potential to improve both lice management and fish health. We are excited to support the company as it moves into commercialization,” said Stian Grieg, Investment Manager at Grieg Kapital.

“There is a clear shift in the salmon industry toward stronger focus on fish health and greater adoption of new technology. Through Blue Revolution Fund, we invest in next-generation aquaculture solutions that improve health and sustainability. Together with a strong and experienced investor consortium, we believe Biosort is well positioned to contribute to the next phase of salmon farming,” said Carsten Krome, Managing Partner at Hatch Blue.

Related Posts

Oceanloop secures up to €38.5 million to scale Europe’s first farmed Giant Grouper

Oceanloop secures up to €38.5 million to scale Europe’s first farmed Giant Grouper

Hatch Blue's Blue Revolution Fund joins Oceanloop as new equity lead-investor, alongside Stolt Ventures and the European Investment Bank. The financing supports the development of a 250-ton Giant Grouper farm in Kiel and a 2,000-ton commercial facility in Gran Canaria.
Hatch Blue Invests $2m in Nernst Electric from Blue Revolution Fund

Hatch Blue Invests $2m in Nernst Electric from Blue Revolution Fund

The technology brings on-site oxygen generation to fish farms, addressing a critical and costly operational dependency across the sector. The transformational potential of Nernst's technology extends far beyond aquaculture, with broad industrial reach.
Atlantic Canada Aquaculture Innovation Studio launches in St. John’s

Atlantic Canada Aquaculture Innovation Studio launches in St. John’s

Ten early-stage aquaculture, aquatech and marine biotechnology companies from across the region are ready to start building toward investable, market-ready businesses.
Kuehnle AgroSystems Secures Series B to Accelerate Commercial Production of Sustainable Natural Astaxanthin

Kuehnle AgroSystems Secures Series B to Accelerate Commercial Production of Sustainable Natural Astaxanthin

Investment led by Ichthus Venture Capital (IVC), alongside existing investors S2G Investments, Hatch Blue and new investor, Dest EOOD, will accelerate manufacturing scale-up and strategic partnership with Corbion.